The nasal cannula is widely regarded as a safe and effective means of administering low- and high-flow oxygen to patients irrespective of their age. However, variability in delivered oxygen concentration (FDO2FDO2) via nasal cannula has the potential to pose health risks. The present study aimed to evaluate predictive equations for FDO2 over a large parameter space, including variation in breathing, oxygen flow, and upper-airway geometry representative of both young children and adults.
METHODS:
Realistic nasal airway geometries were previously collected from medical scans of adults, infants, and neonates. Nasal airway replicas based on these geometries were used to measure the FDO2 for low-flow oxygen delivery during simulated spontaneous breathing. The present study extends previously published data sets to include higher oxygen flows. The extended data sets included nasal cannula oxygen flows that ranged from 6 to 65 L/min for the adult replicas, and from 0.5 to 6 L/min for the infant replicas. For both age groups, FDO2 was measured over a range of breathing frequencies, inspiratory to expiratory time ratios, and tidal volumes. Measured FDO2 values were compared with values predicted by using a previously derived flow-weighted equation.
RESULTS:
For both age groups, FDO2 was observed to increase nonlinearly with the ratio between oxygen flow supplied to the nasal cannula and the average inhalation flow. The previously derived flow-weighted equation over-predicted FDO2 at higher oxygen flows. A new empirical equation, therefore, was proposed to predict FDO2 for either age group as a function of nasal cannula flow, tidal volume, and inspiratory time. Predicted FDO2 values matched measured values, with average relative errors of 2.4% for infants and 4.3% for adults.
CONCLUSIONS:
A new predictive equation for FDO2 was obtained that accurately matched measured data in both adult and infant airway replicas for low- and high-flow regimens.
AliSK, MohammedN, QureshiN, GuptaS. Oxygen therapy in preterm infants: recommendations for practice. J Paediatr Child Health, 2021; 31(1):1-6.
4.
WalshBK, SmallwoodCD. Pediatric oxygen therapy: a review and update. Respir Care, 2017; 62(6):645-661.
5.
BeasleyR, ThayabaranD, BardsleyG. The acute use of oxygen therapy in adults. Malta Med J, 2017; 29(2):14-21.
6.
AustinMA, WillsKE, BlizzardL, WaltersEH, Wood-BakerR. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ, 2010; 341:c5462.
7.
Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: British Thoracic Society; 2016:58.
8.
BatemanED, HurdSS, BarnesPJ, BousquetJ, DrazenJM, FitzGeraldM, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J, 2008; 31(1):143-178.
9.
ChienJW, CiufoR, NovakR, SkowronskiM, NelsonJ, CorenoA, McFaddenERJr. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest, 2000; 117(3):728-733.
10.
RodrigoGJ, VerdeMR, PeregalliV, RodrigoC. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest, 2003; 124(4):1312-1317.
11.
PerrinK, WijesingheM, HealyB, WadsworthK, BowditchR, BibbyS, et al. Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax, 2011; 66(11):937-941.
12.
PatelB, KhineH, ShahA, SungD, MedarS, SingerL. Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma. Pediatr Pulmonol, 2019; 54(7):970-976.
13.
JacobsSS. Clinician strategies to improve the care of patients using supplemental oxygen. Chest, 2019; 156(3):619-628.
14.
MagnetFS, SchwarzSB, CallegariJ, CriéeC-P, StorreJH, WindischW. Long-term oxygen therapy: comparison of the German and British guidelines. Respiration, 2017; 93(4):253-263.
15.
SankaranD, RawatM, LakshminrusimhaS. Optimal oxygen use in neonatal advanced cardiopulmonary resuscitation—a literature review. Pediatr Med, 2023; 6(11):16.
16.
RobbinsME, SaugstadOD. Oxygen for newborn resuscitation: a narrative review. Pediatr Med, 2023; 6:28.
KutzscheS, IlvesP, KirkebyOJ, SaugstadOD. Hydrogen peroxide production in leukocytes during cerebral hypoxia and reoxygenation with 100% or 21% oxygen in newborn piglets. Pediatr Res, 2001; 49(6):834-842.
19.
SaugstadOD. Oxygen for newborns: how much is too much?. J Perinatol, 2005; 25 Suppl 2(2):S45-S49; discussion S50.
20.
KhalilM, JuxC, RueblingerL, BehrjeJ, EsmaeiliA, SchranzD. Acute therapy of newborns with critical congenital heart disease. Transl Pediatr, 2019; 8(2):114-126.
21.
ChenJZ, KatzIM, PichelinM, ZhuK, CaillibotteG, NogaML, et al. Comparison of pulsed versus continuous oxygen delivery using realistic adult nasal airway replicas. Int J Chron Obstruct Pulmon Dis, 2017; 12:2559-2571.
22.
KatzI, ChenJ, DuongK, ZhuK, PichelinM, CaillibotteG, MartinAR. Dose variability of supplemental oxygen therapy with open patient interfaces based on in vitro measurements using a physiologically realistic upper airway model. Respir Res, 2019; 20(1):149.
23.
ChenJZ, KatzIM, PichelinM, ZhuK, CaillibotteG, FinlayWH, MartinAR. In vitro–in silico comparison of pulsed oxygen delivery from portable oxygen concentrators versus continuous flow oxygen delivery. Respir Care, 2019; 64(2):117-129.
24.
WettsteinRB, ShelledyDC, PetersJI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care, 2005; 50(5):604-609.
25.
BazuayeEA, StoneTN, CorrisPA, GibsonGJ. Variability of inspired oxygen concentration with nasal cannulas. Thorax, 1992; 47(8):609-611.
26.
SungV, MassieJ, HochmannMA, CarlinJB, JamsenK, RobertsonCF. Estimating inspired oxygen concentration delivered by nasal prongs in children with bronchiolitis. J Paediatr Child Health, 2008; 44(1-2):14-18.
27.
FanLL, VoylesJB. Determination of inspired oxygen delivered by nasal cannula in infants with chronic lung disease. J Pediatr, 1983; 103(6):923-925.
28.
FinerNN, BatesR, TomatP. Low flow oxygen delivery via nasal cannula to neonates. Pediatr Pulmonol, 1996; 21(1):48-51.
29.
VainNE, PrudentLM, StevensDP, WeeterMM, MaiselsMJ. Regulation of oxygen concentration delivered to infants via nasal cannulas. Am J Dis Child, 1989; 143(12):1458-1460.
30.
SabzM, TaverniniS, PillayK, ChristiansonC, NogaM, FinlayWH, et al. Variability in low-flow oxygen delivery by nasal cannula evaluated in neonatal and infant airway replicas. Respir Res, 2022; 23(1):333.
31.
BeasleyR, AldingtonS, RobinsonG. Is it time to change the approach to oxygen therapy in the breathless patient?. Thorax, 2007; 62(10):840-841.
32.
MulryanC. A new approach to oxygen therapy in adults. BJHCA, 2009; 3(3):129-132.
33.
KapadiaV, WyckoffMH. Oxygen therapy in the delivery room: what is the right dose?. Clin Perinatol, 2018; 45(2):293-306.
34.
ChenDY, ZeeED, GildengorinG, FongEW. A pilot study of heated and humidified low flow oxygen therapy: an assessment in infants with mild and moderate bronchiolitis (HHOT AIR study). Pediatr Pulmonol, 2019; 54(5):620-627.
35.
BenaronDA, BenitzWE. Maximizing the stability of oxygen delivered via nasal cannula. Arch Pediatr Adolesc Med, 1994; 148(3):294-300.
36.
DuprezF, MashayekhiS, CuvelierG, LegrandA, ReychlerG. A new formula for predicting the fraction of delivered oxygen during low-flow oxygen therapy. Respir Care, 2018; 63(12):1528-1534.
37.
TsengH-Y, YangS-H, ChiangH-S. Impact of oxygen concentration delivered via nasal cannula on different lung conditions: a bench study. Healthcare (Basel), 2021:9 (9):1235.
38.
SivieriEM, GerdesJS, AbbasiS. Effect of HFNC flow rate, cannula size, and nares diameter on generated airway pressures: an in vitro study. Pediatr Pulmonol, 2013; 48(5):506-514.
39.
WilkinsJVJr, GardnerMT, WalengaR, HosseiniS, LongestPW, GolshahiL. Mechanistic understanding of high flow nasal cannula therapy and pressure support with an in vitro infant model. Ann Biomed Eng, 2020; 48(2):624-633.
40.
LimD-J, SkinnerD, WestJM, AyinalaS, ZhangS, GraysonJW, et al. In vitro evaluation of a novel oxygen‐generating biomaterial for chronic rhinosinusitis therapy, Int Forum Allergy Rhinol, 2022; 12(2):181-190.
41.
MartinAR, KatzIM, LipsitzY, TerzibachiK, CaillibotteG, TexereauJ. Methods for evaluation of helium/oxygen delivery through non-rebreather facemasks. Med Gas Res, 2012; 2(1):31.
FinlayWH. The mechanics of inhaled pharmaceutical aerosols: an introduction: San Diego: Academic press; Elsevier; 2001.
44.
NumaAH, NewthCJ. Anatomic dead space in infants and children. J Appl Physiol (1985), 1996; 80(5):1485-1489.
45.
ClarkeJR, AstonH, SilvermanM. Evaluation of a tidal expiratory flow index in healthy and diseased infants. Pediatr Pulmonol, 1994; 17(5):285-290.
46.
SchmalischG, WauerRR, FoitzikB, PatzakA. Influence of preterm onset of inspiration on tidal breathing parameters in infants with and without CLD. Respir Physiol Neurobiol, 2003; 135(1):39-46.
47.
PhelanP, WilliamsH, FreemanM. The disturbances of ventilation in acute viral bronchiolitis. J Paediatrics Child Health Paediatr Child Health, 1968; 4(2):96-104.
48.
ChatilaW, NugentT, VanceG, GaughanJ, CrinerGJ. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest, 2004; 126(4):1108-1115.
49.
HudgelDW, MartinRJ, CapehartM, JohnsonB, HillP. Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. J Appl Physiol Respir Environ Exerc Physiol, 1983; 55(3):669-677.
50.
PapoffP, CarestaE, LucianiS, PierangeliA, ScagnolariC, GianniniL, et al. The starting rate for high‐flow nasal cannula oxygen therapy in infants with bronchiolitis: is clinical judgment enough?. Pediatr Pulmonol, 2021; 56(8):2611-2620.
51.
WeilerT, KamerkarA, HotzJ, RossPA, NewthCJ, KhemaniRG. The relationship between high flow nasal cannula flow rate and effort of breathing in children. J Pediatr, 2017; 189:66-71.e3.
52.
MilésiC, PierreA-F, DehoA, PouyauR, LietJ-M, GuillotC, et al. GFRUP Respiratory Study Group. A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2). Intensive Care Med, 2018; 44(11):1870-1878.
53.
Abu-SultanehS, IyerNP, FernándezA, GaiesM, González-DambrauskasS, HotzJC, et al. Executive summary: international clinical practice guidelines for pediatric ventilator liberation, a Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network document. Am J Respir Crit Care Med, 2023; 207(1):17-28.
54.
FratJ-P, CoudroyR, MarjanovicN, ThilleAW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann Transl Med, 2017; 5(14):297.
55.
ParkS. High-flow nasal cannula for respiratory failure in adult patients. Acute Crit Care, 2021; 36(4):275-285.
56.
KuluzJW, McLaughlinGE, GelmanB, CantwellGP, ThomasJ, MahonT, SchleienCL. The fraction of inspired oxygen in infants receiving oxygen via nasal cannula often exceeds safe levels. Respir Care, 2001; 46(9):897-901.
57.
Pons-OdenaM, PalancaD, ModestoV, EstebanE, González-LamuñoD, CarrerasR, PalomequeA. SpO2/FiO2 as a predictor of non-invasive ventilation failure in children with hypoxemic respiratory insufficiency. J Pediatr Intensive Care, 2013; 2(3):111-119.
58.
LeteurtreS, DupréM, DorkenooA, LampinM-E, LeclercF. Assessment of the Pediatric Index of Mortality 2 with the Pao2/Fio2 ratio derived from the Spo2/Fio2 ratio: a prospective pilot study in a French pediatric intensive care unit. Pediatr Crit Care Med, 2011; 12(4):e184-e186.
59.
WeiJ, TangJW, BorojeniAAT, YinS, MartinA, FinlayWH, LiY. Low re-inhalation of the exhaled flow during normal nasal breathing in a pediatric airway replica. Build Environ, 2016; 97:40-47.
60.
O'Reilly NugentA, KellyPT, StantonJ, SwanneyMP, GrahamB, BeckertL. Measurement of oxygen concentration delivered via nasal cannulae by tracheal sampling. Respirology, 2014; 19(4):538-543.
